{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:39:07Z","timestamp":1793299147714,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.metabol.2024.155997","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T22:21:13Z","timestamp":1723501273000},"page":"155997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Management of patients with the cardio renal liver metabolic syndrome: The need for a multidisciplinary approach in research, education and practice"],"prefix":"10.1016","volume":"159","author":[{"given":"Angeliki M.","family":"Angelidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Sanoudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.155997_bb0005","author":"World Health Organization"},{"key":"10.1016\/j.metabol.2024.155997_bb0010","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.metabol.2024.155997_bb0015","author":"World Health Organization. Regional Office for Europe"},{"issue":"25","key":"10.1016\/j.metabol.2024.155997_bb0020","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.metabol.2024.155997_bb0025","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007\u20132008 to 2015\u20132016","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.metabol.2024.155997_bb0030","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-023-00858-9","article-title":"Current and future pharmacotherapies for obesity in children and adolescents","volume":"19","author":"Kelly","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2024.155997_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155919","article-title":"Obesity and dyslipidemia in early life: impact on cardiometabolic risk","volume":"156","author":"Zeljkovic","year":"2024","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.metabol.2024.155997_bb0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.21037\/tp.2017.10.02","article-title":"Metabolic syndrome in children and adolescents","volume":"6","author":"Al-Hamad","year":"2017","journal-title":"Transl Pediatr"},{"key":"10.1016\/j.metabol.2024.155997_bb0045","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.metabol.2024.155997_bb0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter-organ cross-talk in metabolic syndrome","volume":"1","author":"Priest","year":"2019","journal-title":"Nat Metab"},{"issue":"9","key":"10.1016\/j.metabol.2024.155997_bb0055","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947903","article-title":"Inter-organ communication: a gatekeeper for metabolic health","volume":"20","author":"Castillo-Armengol","year":"2019","journal-title":"EMBO Rep"},{"issue":"22","key":"10.1016\/j.metabol.2024.155997_bb0060","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.3390\/jcm11226637","article-title":"Organ crosstalk in acute kidney injury: evidence and mechanisms","volume":"11","author":"Li","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.metabol.2024.155997_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41574-023-00898-1","article-title":"Inter-organ crosstalk during development and progression of type 2 diabetes mellitus","volume":"20","author":"Xourafa","year":"2024","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"10.1016\/j.metabol.2024.155997_bb0070","first-page":"1039","article-title":"Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk [published correction appears in Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):e151]","volume":"28","author":"Despr\u00e9s","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 4","key":"10.1016\/j.metabol.2024.155997_bb0075","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0802853","article-title":"Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus","volume":"28","author":"Heilbronn","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"18","key":"10.1016\/j.metabol.2024.155997_bb0080","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIR.0b013e318233bc6a","article-title":"Assessing adiposity: a scientific statement from the American Heart Association","volume":"124","author":"Cornier","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.metabol.2024.155997_bb0085","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/met.2023.0006","article-title":"The bidirectional association of chronic kidney disease, type 2 diabetes, atherosclerotic cardiovascular disease, and heart failure: the cardio-renal-metabolic syndrome","volume":"21","author":"Nichols","year":"2023","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"10.1016\/j.metabol.2024.155997_bb0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.arr.2010.04.007","article-title":"Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer\u2019s disease","volume":"9","author":"Frisardi","year":"2010","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.metabol.2024.155997_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155937","article-title":"Obesity and MASLD: is weight loss the (only) key to treat metabolic liver disease?","author":"Huttasch","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155997_bb0100","article-title":"Metabolic liver disease in diabetes - from mechanisms to clinical trials","volume":"111S","author":"Dewidar","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155997_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155689","article-title":"Milestones in the journey towards addressing obesity; past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery","volume":"148","author":"Kokkorakis","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155997_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155931","article-title":"DCRM 2.0: multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases","author":"Handelsman","year":"2024","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.metabol.2024.155997_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108389","article-title":"Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases","volume":"37","author":"Handelsman","year":"2023","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.metabol.2024.155997_bb0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","article-title":"Obesity, adipose tissue and vascular dysfunction","volume":"128","author":"Koenen","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2024.155997_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155332","article-title":"Pharmacotherapy of type 2 diabetes: an update and future directions","volume":"137","author":"DeMarsilis","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155997_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154918","article-title":"Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease","volume":"126","author":"Liu","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155997_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.155997_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155835","article-title":"Resmetirom, the first approved drug for the management of metabolic dysfunction-associated steatohepatitis: trials, opportunities, and challenges","volume":"154","author":"Kokkorakis","year":"2024","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.metabol.2024.155997_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2013.250","article-title":"Cardiorenal syndrome\u2014current understanding and future perspectives","volume":"10","author":"Braam","year":"2014","journal-title":"Nat Rev Nephrol"},{"issue":"23","key":"10.1016\/j.metabol.2024.155997_bb0150","first-page":"2493","article-title":"Designing health care for the most common chronic condition\u2014multimorbidity [published correction appears in JAMA. Jul 18, 2012;308(3):238]","volume":"307","author":"Tinetti","year":"2012","journal-title":"JAMA"},{"issue":"10131","key":"10.1016\/j.metabol.2024.155997_bb0155","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(18)30941-3","article-title":"Making more of multimorbidity: an emerging priority","volume":"391","author":"The Lancet","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.metabol.2024.155997_bb0160","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cger.2016.01.013","article-title":"Epidemiology of multimorbidity in older adults with cardiovascular disease","volume":"32","author":"Bell","year":"2016","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.metabol.2024.155997_bb0165","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev-publhealth-032315-021439","article-title":"Racial and ethnic disparities in the quality of health care","volume":"37","author":"Fiscella","year":"2016","journal-title":"Annu Rev Public Health"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524002245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T10:27:34Z","timestamp":1725272854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524002245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":33,"alternative-id":["S0026049524002245"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155997","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of patients with the cardio renal liver metabolic syndrome: The need for a multidisciplinary approach in research, education and practice","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.155997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155997"}}